FFO
NGNE icon

Fortitude Family Office’s Neurogene NGNE Stock Holding History

Fortitude Family Office’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252 Buy
+8
New +$220 ﹤0.01% 2087

Other funds holding NGNE

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fortitude Family Office's NGNE Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Neurogene (NGNE) in Q2 2026: 8 shares worth $252. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings.

10 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Fortitude Family Office held 8 shares of Neurogene worth $252 as of Q2 2026.
  • Neurogene was a new Fortitude Family Office position in Q2 2026.
  • Neurogene made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2087 holding.
  • 10 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.